Standard BioTools Free Cash Flow 2010-2024 | LAB
Standard BioTools free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Standard BioTools Annual Free Cash Flow |
| 2024 |
-151.81 |
| 2023 |
-46.12 |
| 2022 |
-93.20 |
| 2021 |
-57.33 |
| 2020 |
-28.13 |
| 2019 |
-37.74 |
| 2018 |
-25.57 |
| 2017 |
-25.66 |
| 2016 |
-44.20 |
| 2015 |
-38.72 |
| 2014 |
-30.03 |
| 2013 |
-5.04 |
| 2012 |
-19.86 |
| 2011 |
-19.22 |
| 2010 |
-13.04 |
| 2009 |
-20.20 |
| Standard BioTools Quarterly Free Cash Flow |
| 2024-12-31 |
-151.81 |
| 2024-09-30 |
-134.37 |
| 2024-06-30 |
-104.24 |
| 2024-03-31 |
-63.26 |
| 2023-12-31 |
-46.12 |
| 2023-09-30 |
-31.98 |
| 2023-06-30 |
-19.66 |
| 2023-03-31 |
-9.50 |
| 2022-12-31 |
-93.20 |
| 2022-09-30 |
-73.26 |
| 2022-06-30 |
-47.38 |
| 2022-03-31 |
-16.46 |
| 2021-12-31 |
-57.33 |
| 2021-09-30 |
-49.86 |
| 2021-06-30 |
-38.66 |
| 2021-03-31 |
-19.82 |
| 2020-12-31 |
-28.13 |
| 2020-09-30 |
-13.69 |
| 2020-06-30 |
-8.76 |
| 2020-03-31 |
-5.33 |
| 2019-12-31 |
-37.74 |
| 2019-09-30 |
-31.72 |
| 2019-06-30 |
-25.83 |
| 2019-03-31 |
-20.40 |
| 2018-12-31 |
-25.57 |
| 2018-09-30 |
-24.92 |
| 2018-06-30 |
-20.65 |
| 2018-03-31 |
-16.25 |
| 2017-12-31 |
-25.66 |
| 2017-09-30 |
-26.15 |
| 2017-06-30 |
-17.61 |
| 2017-03-31 |
-9.18 |
| 2016-12-31 |
-44.20 |
| 2016-09-30 |
-32.78 |
| 2016-06-30 |
-17.81 |
| 2016-03-31 |
-8.94 |
| 2015-12-31 |
-38.72 |
| 2015-09-30 |
-32.87 |
| 2015-06-30 |
-19.94 |
| 2015-03-31 |
-10.71 |
| 2014-12-31 |
-30.03 |
| 2014-09-30 |
-25.02 |
| 2014-06-30 |
-14.80 |
| 2014-03-31 |
-12.36 |
| 2013-12-31 |
-5.04 |
| 2013-09-30 |
-6.39 |
| 2013-06-30 |
-4.43 |
| 2013-03-31 |
-1.58 |
| 2012-12-31 |
-19.86 |
| 2012-09-30 |
-15.60 |
| 2012-06-30 |
-11.88 |
| 2012-03-31 |
-7.04 |
| 2011-12-31 |
-19.22 |
| 2011-09-30 |
-16.28 |
| 2011-06-30 |
-13.62 |
| 2011-03-31 |
-1.45 |
| 2010-12-31 |
-13.04 |
| 2010-09-30 |
-10.38 |
| 2010-06-30 |
-6.69 |
| 2010-03-31 |
-3.31 |
| 2009-09-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$0.456B |
$0.174B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
